Werner Marius, Brinkhofer Julian, Hammermüller Leon, Heim Thomas, Pham Truc Lam, Huber Jonas, Klein Christian, Thomas Franziska
Institute of Organic Chemistry, Heidelberg University, Im Neuenheimer Feld 270, 69120, Heidelberg, Germany.
Medicinal Chemistry, Institute of Pharmacy and Molecular Biotechnology (IPMB), Heidelberg University, Im Neuenheimer Feld 364, 69120, Heidelberg, Germany.
Adv Sci (Weinh). 2024 Jul;11(28):e2400640. doi: 10.1002/advs.202400640. Epub 2024 May 29.
Organoboron compounds have a wide range of applications in numerous research fields, and methods to incorporate them in biomolecules are much sought after. Here, on-resin chemical syntheses of aliphatic and vinylogous peptide boronic acids are presented by transition metal-catalyzed late-stage hydroboration of alkene and alkyne groups in peptides and peptoids, for example on allyl- and propargylglycine residues, using readily available chemicals. These methods yield peptide boronic acids with much shorter linkers than previously reported on-resin methods. Furthermore, the methods are regio- and stereoselective, compatible with all canonical amino acid residues and can be applied to short, long, and in part even "difficult" peptide sequences. In a feasibility study, the protected peptide vinylboronic acids are further derivatized by the Petasis reaction using salicylaldehyde derivatives. The ability of the obtained peptide boronic acids to reversibly bind to carbohydrates is demonstrated in a catch-release model experiment using a fluorescently labeled peptide boronic acid on cross-linked dextran beads. In summary, this highlights the potential of the target compounds for drug discovery, glycan-specific target recognition, controlled release, and diagnostics.
有机硼化合物在众多研究领域有着广泛的应用,将其引入生物分子的方法备受关注。在此,通过过渡金属催化肽和类肽中烯烃和炔烃基团(例如烯丙基甘氨酸和炔丙基甘氨酸残基)的后期硼氢化反应,利用易得的化学试剂,展示了脂肪族和乙烯型肽硼酸在树脂上的化学合成方法。这些方法所产生的肽硼酸的连接子比先前报道的树脂法要短得多。此外,这些方法具有区域选择性和立体选择性,与所有标准氨基酸残基兼容,并且可应用于短、长甚至部分“困难”的肽序列。在一项可行性研究中,使用水杨醛衍生物通过Petasis反应对受保护的肽乙烯硼酸进行进一步衍生化。在交联葡聚糖珠上使用荧光标记的肽硼酸进行的捕获 - 释放模型实验中,证明了所得肽硼酸与碳水化合物可逆结合的能力。总之,这突出了目标化合物在药物发现、聚糖特异性靶标识别、控释和诊断方面的潜力。